CanSino Biologics Inc. (CASBF)
OTCMKTS · Delayed Price · Currency is USD
4.474
-0.271 (-5.71%)
At close: Jan 22, 2026
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of $1.64 billion as of February 12, 2026. Its market cap has increased by 19.48% in one year.
Market Cap
1.64B
Enterprise Value
1.45B
Revenue
136.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.47
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 964.53M to 1.64B, an increase of 70.26%. That is a compound annual growth rate of 8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.67B | 2.65% |
| Dec 31, 2025 | 1.62B | 8.58% |
| Dec 31, 2024 | 1.49B | -6.70% |
| Dec 29, 2023 | 1.60B | -54.89% |
| Dec 30, 2022 | 3.55B | -58.11% |
| Dec 31, 2021 | 8.48B | -11.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 710.47M |
| Elite Pharmaceuticals | 464.34M |
| Nika Pharmaceuticals | 403.38M |
| Jushi Holdings | 99.87M |
| Growth Stalk Holdings | 77.83M |
| Sofgen Pharma | 55.75M |
| Radnostix | 50.50M |
| Earth Science Tech | 39.43M |